Post-op cataract drops? They could be out, according to some top surgeons. For Drs. Brian Shafer, Scott LaBorwit, Jeffrey Martin, and Paul Singh, Rayner’s dropless regimen with OMIDRIA is in.
As the first and only FDA-approved non-opioid intracameral NSAID, OMIDRIA tackles inflammation at the source—simplifying recovery, reducing surgeon, patient, and clinic stress, and giving cataract surgeons a streamlined way to deliver care. Watch now to discover their stories of going dropless.
For more, browse the OMIDRIA content at omidria.com
OMIDRIA videos are for US HCPs only. This is a studied postoperative cataract surgery regimen that may not be for everyone. Rayner does not recommend any specific combination use of products. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
US-OM-2500043 06/25
